199 related articles for article (PubMed ID: 38129319)
1. Ramipril therapy in integrin α1-null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA-seq analysis.
Madison J; Wilhelm K; Meehan DT; Gratton MA; Vosik D; Samuelson G; Ott M; Fascianella J; Nelson N; Cosgrove D
J Pathol; 2024 Mar; 262(3):296-309. PubMed ID: 38129319
[TBL] [Abstract][Full Text] [Related]
2. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1.
Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D
J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980
[TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
[TBL] [Abstract][Full Text] [Related]
4. α1β1 integrin/Rac1-dependent mesangial invasion of glomerular capillaries in Alport syndrome.
Zallocchi M; Johnson BM; Meehan DT; Delimont D; Cosgrove D
Am J Pathol; 2013 Oct; 183(4):1269-1280. PubMed ID: 23911822
[TBL] [Abstract][Full Text] [Related]
5. Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.
Dufek B; Meehan DT; Delimont D; Cheung L; Gratton MA; Phillips G; Song W; Liu S; Cosgrove D
Kidney Int; 2016 Aug; 90(2):300-310. PubMed ID: 27165837
[TBL] [Abstract][Full Text] [Related]
6. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
7. Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.
Delimont D; Dufek BM; Meehan DT; Zallocchi M; Gratton MA; Phillips G; Cosgrove D
PLoS One; 2014; 9(6):e99083. PubMed ID: 24915008
[TBL] [Abstract][Full Text] [Related]
8. X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.
Clark SD; Nabity MB; Cianciolo RE; Dufek B; Cosgrove D
PLoS One; 2016; 11(12):e0168343. PubMed ID: 27959966
[TBL] [Abstract][Full Text] [Related]
9. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.
Ning L; Suleiman HY; Miner JH
Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of a Human Laminin
Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
[TBL] [Abstract][Full Text] [Related]
11. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.
Cosgrove D; Rodgers K; Meehan D; Miller C; Bovard K; Gilroy A; Gardner H; Kotelianski V; Gotwals P; Amatucci A; Kalluri R
Am J Pathol; 2000 Nov; 157(5):1649-59. PubMed ID: 11073824
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome.
Cosgrove D; Meehan DT; Delimont D; Pozzi A; Chen X; Rodgers KD; Tempero RM; Zallocchi M; Rao VH
Am J Pathol; 2008 Mar; 172(3):761-73. PubMed ID: 18258846
[TBL] [Abstract][Full Text] [Related]
15. The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome.
Wang H; Yue Z; Wu J; Liu T; Mo Y; Jiang X; Sun L
PLoS One; 2015; 10(8):e0135648. PubMed ID: 26274923
[TBL] [Abstract][Full Text] [Related]
16. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport mice.
Cosgrove D; Gratton MA; Madison J; Vosik D; Samuelson G; Meehan D; Delimont D; Phillips G; Smyth B; Pramparo T; Jarocki D; Nguyen M; Komers R; Jenkinson C
J Pathol; 2023 Jul; 260(3):353-364. PubMed ID: 37256677
[TBL] [Abstract][Full Text] [Related]
18. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
Abrahamson DR; Prettyman AC; Robert B; St John PL
Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
[TBL] [Abstract][Full Text] [Related]
19. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
20. Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome.
Lin MH; Miller JB; Kikkawa Y; Suleiman HY; Tryggvason K; Hodges BL; Miner JH
J Am Soc Nephrol; 2018 May; 29(5):1426-1436. PubMed ID: 29472414
[No Abstract] [Full Text] [Related]
[Next] [New Search]